| Literature DB >> 34204433 |
Mahendra P Kapoor1, Masaaki Sugita2, Yoshitaka Fukuzawa3, Derek Timm4, Makoto Ozeki1, Tsutomu Okubo1.
Abstract
Catechins are a part of the chemical family of flavonoids, a naturally occurring antioxidant, and a secondary metabolite in certain plants. Green tea catechins are well recognized for their essential anti-inflammatory, photo-protective, antioxidant, and chemo-preventive functions. Ultraviolet radiation is a principal cause of damage to the skin. Studies observed that regular intake of green tea catechins increased the minimal dose of radiation required to induce erythema. The objectives of this systematic review and meta-analysis are to determine the effectiveness of green tea catechins in cutaneous erythema and elucidate whether green tea catechin consumption protects against erythema (sunburn) inflammation. A comprehensive literature search was conducted to identify the relevant studies. Two researchers carried out independent screening, data extraction, and quality assessment according to the guidelines of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA). The pooled effect of green tea catechins on protection against erythema was assessed using approaches fixed-effects or random-effects model to quantify the effectiveness of green tea catechins in the erythema dose-response. Studies not be included in meta-analyses were summarized narratively. Six randomized controlled studies of enrolled studies regularly administrated green tea catechins orally for 6 to 12 weeks involving healthy volunteers comprising a total of 100 participants were included in the analysis. The results revealed green tea catechins have favorable protection against erythema inflammation even at increased minimal erythema dose (MED) of ultraviolet radiation. Meta-analysis results confirm oral supplementation of green tea catechins is highly effective at low-intensity ultraviolet radiation-induced erythema response (MED range; 1.25-1.30) compared to placebo, showing a significant pooling difference (p = 0.002) in erythema index (SMD: -0.35; 95% CI, -0.57 to -0.13; I2 = 4%, p = 0.40) in the random-effects model. The pro-inflammatory signaling pathways through oral supplementation with green tea catechins are an attractive strategy for photo-protection in healthy human subjects and could represent a complementary approach to topical sunscreens. Therefore, studies that involved green tea catechin in topical applications to human subjects were also evaluated separately, and their meta-analysis is presented as a reference. The evidence indicates that regular green tea catechin supplementation is associated with protection against UV-induced damage due to erythema inflammation.Entities:
Keywords: erythema (sunburn); green tea catechins; meta-analysis; skin; ultraviolet radiation
Mesh:
Substances:
Year: 2021 PMID: 34204433 PMCID: PMC8233826 DOI: 10.3390/molecules26123702
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structure of different green tea catechins.
Figure 2Schematic PRISMA flow diagram of included and excluded studies retrieved and identified by individual searches, and evaluated in the systematic review and meta-analysis of the effect of green tea catechins on the ultraviolet irradiation-induced erythema response.
Characteristics features and methodological assessments of the included studies evaluated in the meta-analysis of green tea catechin’s effect on ultraviolet irradiation-induced erythema response in healthy humans.
| Study | Study | Study | Dosage/ | Study Duration | Study | x. MED | Meta-Analysis Parameters | Study Details/ |
|---|---|---|---|---|---|---|---|---|
| Farrar et al., 2015 | Randomized Double-blind Placebo controlled (RCT) | Healthy adults (male and female) GTC 25; Placebo 25 Age 18–65 years | Capsules GTC, 1080 mg | 12 weeks | Farrar 2015-a | 1.25–1.30 | Ultraviolet | Studied 10 dosages of simulated Ultraviolet radiation (7–80 mJ/cm2); irradiated sites were examined after 24 h; skin biopsy, analysis of skin blister fluid, urinary analysis of GTC metabolites; Cutaneous production of eicosanoids, Ultraviolet radiation-induced erythema response (threshold value) |
| Rhodes et al., 2013 | Open Oral Intervention Pre- and post- | Healthy adults (male and | Capsules GTC, | 12 weeks | Rhodes 2013-a Rhodes 2013-b Rhodes 2013-c Rhodes 2013-d | 1.0–1.1 | Ultraviolet | Studied 10 dosages of simulated Ultraviolet radiation (6.67–68 mJ/cm2); irradiated sites were examined visually after 24 h; Skin tissues and blister fluid sampling; evaluated cutaneous eicosanoid levels; Urinary metabolites; Ultraviolet radiation-induced erythema Index (threshold value) |
| Heinrich et al., 2011 | Randomized Double-blind | Healthy adults (female) GTC 30; Placebo 30 Age 40–65 years | Capsules GTC, 1402 mg | 6 weeks, and 12 weeks | Heinrich 2011-a Heinrich 2011-b | 1.25 | Ultraviolet | MED estimation; Irradiation with 1.25 MED at wk 0, wk 6, and wk 12 (time points); Erythema measured before and 24 h after exposure; measurement of reddening (a-value); skin elasticity, structure and texture, and hydration and transepidermal water loss. |
| Farrar et al., 2018 | Randomized Double-blind | Healthy adults (male and | Capsules GTC, 1080 mg | 12 weeks | Farrar 2018-a | 3.0 | CPD | Ultraviolet radiation-induced epidermis compared post-supplementation for Immunohistochemically staining with CPDs; Placebo vs. GTC; up to 3xMED erythema dose; studied photoprotection of skin from direct DNA damage. |
| Katiyar et al. 1999 | In-vivo | Healthy adults (male and | GTC (EGCG) | Single-dose | Katiyar 1999 | 4.0 | Ultraviolet | Topical application of GTC (EGCG, 3 mg/2.5 cm2 skin area); Ultraviolet radiation-induced erythema response; Exposures at 4.0 MED; studied MPO and leukocyte inhibition; Cyclooxygenase activity (prostaglandin metabolites) |
| Katiyar et al. 2000 | In-vivo | Healthy adults (male and | GTC (EGCG) | Single-dose | Katiyar 2000-a | 0.50 | Ultraviolet | Topical application of GTC (3 mg/2.5 cm2 skin area); Ultraviolet radiation-induced erythema response; Exposures at 0.5–4.0 MED; Skin punch biopsies; Immunostaining of CPDs (Ultraviolet radiation dose-dependent at epidermis level) |
PGE2, Prostaglandin E2; 12-HETE, 12-Hydroxyeicosatetraenoicacid; CPD, Cyclobutane pyrimidine dimers; MED = Minimal Erythema Dose; GTC= Green Tea Catechins. # Study descriptions: Substudies assigned as a, b, c, d are the included data trial points of selected studies.
Assessment of validity, risk of bias, and Jadad score of the included eligible studies evaluated in the meta-analysis.
| Author and Year | Farrar et al., 2015 | Rhodes et al., 2013 | Heinrich et al., 2011 | Farrar et al., 2018 | Katiyar et al., 1999 | Katiyar et al., 2000 |
|---|---|---|---|---|---|---|
| Reference No. | [ | [ | [ | [ | [ | [ |
| Study type | Oral | Oral | Oral | Oral | Topical | Topical |
| Allocation Concealment | Adequate | Adequate | Adequate | Adequate | Adequate | Adequate |
| Sequence Generation | Yes | Yes | Yes | Yes | No | No |
| Randomization | Yes | Yes | Yes | Yes | No | No |
| Blinding | Yes | Yes | Yes | Yes | No | No |
| Incomplete Outcome | No | No | No | No | No | No |
| Withdrawal/Other reporting | Yes | Yes | Yes | Yes | Yes | Yes |
| Jadad Score | 5 | 4 | 5 | 5 | 2 | 2 |
Figure 3Meta-analysis of the effect of the varying dosages of green tea catechin supplementation on ultraviolet radiation-induced erythema response. (a) Forest plot of randomized controlled studies in healthy adults comparing the effect of before (pre-) and after (post-) oral green tea catechin interventions at MED challenge ranges between 1.0–2.5; (b) Funnel plot of representative oral green tea catechin supplementation studies (c) Forest plot of studies in healthy adults comparing the effect of before (pre-) and after (post-) topically applied green tea catechins at MED challenge ranges between 1.0–2.5; (d) Funnel plot of representative topically applied green tea catechin studies. (e) Forest plot of studies in healthy adults comparing the effect of before (pre-) and after (post-) topically applied green tea catechins at MED challenge ranges between 0.5–4.0; (f) Funnel plot of representative topically applied green tea catechin studies. Data are presented as mean and SDs, and the effect of studies is presented as weight (percentage) and standardized mean differences (SMDs) at 95% confidence intervals (CIs) using the generic inverse variance (IV) random-effects model. Inter-study heterogeneity was quantified by I2 statistics with significance p ≤ 0.10. The diamond represents the pooled effect estimated for the overall analysis.
A meta-analysis of included studies investigating the effect of green tea catechin supplementation on the ultraviolet irradiation-induced erythema response in humans ranked by selected study characteristics.
| Study | Outcomes Measured | Study/ | Meta-Analysis (Estimation) | Test of Heterogeneity | Pooled | ||
|---|---|---|---|---|---|---|---|
| Inverse Variance, Net Change (95% CI) | Chi-Square Test |
| I2 (%) | ||||
| Oral Intake | |||||||
| Pre-test/ | (i) GTC effect on Erythema Index | 9/175 | a SMD: −0.35 [−0.57, −0.13] | 8.36 | 0.40 | 4 | 0.002 |
| b SMD: −0.35 [−0.56, −0.14] | 8.36 | 0.40 | 4 | 0.001 | |||
| a MD: −1.01 [−1.56, −0.47] | 7.60 | 0.47 | 0 | 0.003 | |||
| b MD: −1.01 [−1.56, −0.47] | 7.60 | 0.47 | 0 | 0.003 | |||
| (ii) GTC effect on Erythema Index | 4/95 | a SMD: −0.49 [−0.78, −0.20] | 2.36 | 0.50 | 0 | 0.0009 | |
| b SMD: −0.49 [−0.78, −0.20] | 2.36 | 0.50 | 0 | 0.0009 | |||
| a MD: −0.99 [−1.54, −0.45] | 1.93 | 0.59 | 0 | 0.0004 | |||
| (iii) Dose–response | 4/70 | a SMD: −0.19 [−0.58, −0.20] | 3.85 | 0.28 | 22 | 0.34 | |
| b SMD: −0.16 [−0.49, 0.18] | 3.85 | 0.28 | 22 | 0.36 | |||
| a MD: −5.24 [−15.16, 4.68] | 4.49 | 0.21 | 33 | 0.3 | |||
| b MD: −4.02 [−11.74, 3.71] | 4.49 | 0.21 | 33 | 0.31 | |||
| (≥1.50) | |||||||
| RCT studies | (i) GTC effect | 5/P132 | a SMD: −0.29 [−0.53, −0.05] | 3.30 | 0.51 | 0 | 0.02 |
| b SMD: −0.29 [−0.53, −0.05] | 3.30 | 0.51 | 0 | 0.02 | |||
| a MD: −1.38 [−2.28, −0.47] | 0.57 | 0.97 | 0 | 0.003 | |||
| b MD: −1.38 [−2.28, −0.47] | 0.57 | 0.97 | 0 | 0.003 | |||
| Topical | |||||||
| Pre-test/ | GTC effect on Erythema Index | 5/28 | a SMD: −4.52 [−7.72, −1.31] | 29.68 | <0.00001 | 87 | 0.006 |
| b SMD: −1.98 [−2.89, −1.07] | 29.70 | <0.00001 | 87 | <0.0001 | |||
| a MD: -6.68 [−11.37, −1.99] | 372.5 | <0.00001 | 99 | 0.005 | |||
| b MD: −4.38 [−4.84, −3.91] | 0.57 | <0.00001 | 99 | <0.00001 | |||
| GTC effect on Erythema Index | 3/18 | a SMD: −3.02 [−6.40, 0.37] | 16.70 | 0.0002 | 88 | 0.08 | |
| b SMD: −1.48 [−2.44, −10.52] | 16.70 | 0.0002 | 88 | 0.002 | |||
| a MD: −3.44 [−7.01, 0.13] | 83.60 | <0.00001 | 98 | 0.06 | |||
| b MD: −2.27 [−2.79, −1.75] | 83.60 | <0.00001 | 98 | <0.00001 | |||
a Random Effect Model; b Fixed Effect Model; SMD: Standardized Mean Difference; MD: Mean Difference. GTC = Green Tea Catechins.
Figure 4Meta-analysis of the effect of the oral green tea catechin supplementation on ultraviolet radiation-induced erythema response at varying UV-irradiation challenges. (a) Forest plot of randomized controlled studies in healthy adults comparing the effect of before (pre−) and after (post-) oral green tea catechin interventions at low-intensity MED challenge ranges between 1.25–1.30; (b) Funnel plot of representative oral green tea catechin supplementation studies. (c) Forest plot of randomized controlled studies in healthy adults comparing the effect of before (pre−) and after (post-) oral green tea catechin interventions at high-intensity MED challenge ≥1.50; (d) Funnel plot of representative oral green tea catechin supplementation studies. As illustrated in Figure 3.
Figure 5(a) Forest plot of randomized controlled studies in healthy adults comparing the effect of oral green tea catechin interventions with placebo showing effectiveness at low intensity (MED challenge ranges between 1.25–1.30) UV-irradiation-induced erythema compared to placebo; (b) Funnel plot of representative oral green tea catechins and placebo supplementation studies. : As illustrated in Figure 3.
Figure 6Forest plot of randomized controlled studies in healthy adults comparing the effect of before (pre−) and after (post-) oral green tea catechin interventions at the varying intensity of MED challenge showed a nonsignificant inhibition of ultraviolet radiation-induced pro-inflammatory mediators. (a) PGE2; (b) 12-HETE, and (c) CPDs. As illustrated in Figure 3. The effect of studies is presented mean differences (MDs) at 95% confidence intervals (CIs) using the generic inverse variance (IV) random-effects model.
Meta-analyses of ultraviolet radiation-induced pro-inflammatory mediator eicosanoids and pyrimidine dimers ranked by green tea catechin supplemented studies on healthy humans.
| Study Characteristics | Outcomes Measured | Study/Subjects | Meta-Analysis (Estimation) | Test of Heterogeneity | Pooled | ||
|---|---|---|---|---|---|---|---|
| Inverse Variance, Net Change (95% CI) | Chi-Square Test |
| I2 (%) | ||||
| Pre-test/ | (i) GTC effect on PGE2 | 2/30 | a MD: −2.93 [−35.61, 28.75] | 0.01 | 0.9 | 0 | 0.86 |
| b MD: −2.93 [−35.61, 28.75] | 0.01 | 0.9 | 0 | 0.86 | |||
| (ii) GTC effect on 12-HETE | 2/34 | a MD: −7.49 [−33.04, 18.05] | 2.75 | 0.1 | 64 | 0.57 | |
| b MD: −2.05 [−14.24, 10.14] | 2.75 | 0.1 | 64 | 0.74 | |||
| (iii) GTC effect on CPD | 4/35 | a MD: −0.03 [−0.30, 0.23] | 0.16 | 0.98 | 0 | 0.79 | |
| b MD: −0.03 [−0.30, 0.23] | 0.16 | 0.98 | 0 | 0.79 | |||
| RCT studies | (i) GTC effect on PGE2 | 1/P21 | a MD: −12.80 [−37.08, 11.48] | na | na | na | 0.3 |
| b MD: −12.80 [−37.08, 11.48] | na | na | na | 0.3 | |||
a Random Effect Model; b Fixed Effect Model; SMD: Standardized Mean Difference; MD: Mean Difference; PGE2, Prostaglandin E2; 12-HETE, 12-Hydroxyeicosatetraenoicacid; CPD, Cyclobutane pyrimidine dimers; GTC = Green Tea Catechins.